The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Acquisition

16 Dec 2022 07:00

RNS Number : 8354J
Chesnara PLC
16 December 2022
 

 

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

 

 

CHESNARA plc (CSN.L)

 

16 December 2022

 

 

UPDATE ON THE ACQUISITION OF CONSERVATRIX'S INSURANCE PORTFOLIO

 

 

Following the announcement on 22 July 2022 of the proposed acquisition of the insurance portfolio of Nederlandsche Algemeene Maatschappij van Levensverzekering "Conservatrix" N.V. ("Conservatrix"), Chesnara plc ("Chesnara") (CSN.L) is pleased to announce that it has now received all necessary Court and Regulatory approvals for the transaction.

 

The acquisition will formally complete on 1 January 2023. The insurance portfolio will be acquired by Waard Leven N.V., Chesnara's Dutch closed book operation.

 

Steve Murray, Chief Executive Officer of Chesnara, stated: 

 

"We are delighted to receive the necessary Court and Regulatory approvals for the acquisition of Conservatrix's insurance portfolio and to be able to welcome the Conservatrix customers and staff to the Chesnara Group from the start of 2023. We recognise that the bankruptcy of Conservatrix has caused significant uncertainty for its customers and employees, but we hope that the acquisition provides certainty and a clear way forward for them.

 

"We believe that acquisition opportunities across our target markets remain strong, and we continue to be highly confident in our ability to finance and execute such transactions on attractive terms for both vendors and our shareholders."

 

 

For further information, please contact:

 

Investor Enquiries

Sam Perowne

Head of Strategic Development & Investor Relations

Chesnara plc

E - sam.perowne@chesnara.co.uk

 

Media Enquiries

Roddy Watt

Director, Capital Markets

FWD

T - 020 7280 0651 / 07714 770 493 

E - roddy.watt@fwdconsulting.co.uk

 

 

 

Notes to Editors

Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured and CASLP in the UK, as The Waard Group, Robein Leven N.V. and Scildon in the Netherlands, and as Movestic in Sweden.

 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 18 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQFFASUIEESESE

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.